Home / Partnerships / Salk Institute for Biological Studies
logo-salk-616-by-435.png

Salk Institute for Biological Studies

NOMIS Partnership

Unlocking the secrets of life itself is the driving force behind the Salk Institute. Salk’s team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: Small by choice, intimate by nature, and fearless in the face of any challenge. The Salk Institute has been a NOMIS partner since 2008. Together, Salk and NOMIS have established the NOMIS Center for Immunobiology and Microbial Pathogenesis and the NOMIS–Salk Fellowship Program.

NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute >
NOMIS–Salk Fellowship Program >
NOMIS Fellow
Salk Institute for Biological Studies
NOMIS Fellow
Salk Institute for Biological Studies
NOMIS Fellow
Salk Institute for Biological Studies
Assistant professor
Salk Institute for Biological Studies
NOMIS Fellow
Salk Institute for Biological Studies
NOMIS Fellow
Salk Institute for Biological Studies
NOMIS Fellow
Salk Institute for Biological Studies
NOMIS Fellow
Salk Institute for Biological Studies
Associate Professor - NOMIS Center for Immunobiology and Microbial Pathogenesis
Salk Institute for Biological Studies
Françoise Gilot-Salk Chair and professor in the Molecular Neurobiology Laboratory
Salk Institute for Biological Studies
NOMIS Foundation Chair and director of the NOMIS Center for Immunobiology and Microbial Pathogenesis
Salk Institute for Biological Studies
Professor in the NOMIS Center for Immunobiology and Microbial Pathogenesis, director of the Molecular and Systems Physiology Laboratory, member of the Gene Expression Laboratory, and Helen McLoraine Developmental Chair
Salk Institute for Biological Studies
Former NOMIS Fellow
Salk Institute for Biological Studies
June 20, 2024
The Salk Institute will receive $20 million over four years from the NOMIS Foundation to launch a new Neuroimmunology Initiative within the Institute’s NOMIS Center for Immunobiology and Microbial Pathogenesis. […]
May 6, 2024
NOMIS Center for Immunobiology and Microbial Pathogenesis Director Susan Kaech and NOMIS researchers Nicholas Christakis and Joanna Wysocka have been elected to the US National Academy of Sciences. They are among 120 […]
April 2, 2024
NOMIS researcher and Salk Institute Professor Janelle Ayres has been elected to the American Academy of Microbiology’s Fellowship Class of 2024. Fellows of the Academy, an honorific leadership group within […]
February 7, 2024
NOMIS Center Director Susan Kaech and NOMIS Fellow Anna-Maria Globig, together with fellow scientists at the Salk Instistute, have discovered that lung adenocarcinoma cancer cells steer macrophage lipid metabolism to […]
November 6, 2023
NOMIS researcher Ye Zheng, former NOMIS Fellow Zhi Liu and fellow researchers at the Salk Institute have discovered that Foxp3 is essential for creating the unique chromatin architecture of regulatory […]
November 3, 2023
The NOMIS Fellowship Programs at ETH Zurich, ISTA and the Salk Institute have been featured in an advertorial in Science. NOMIS Fellows David Brückner, Anna-Maria Globig, Maayan Levy, Zhi Liu and Craig […]
September 20, 2023
NOMIS–Salk Fellow Anna-Maria Globig and NOMIS researcher Susan Kaech, together with their colleagues at the Salk Institute, have found that stress hormones released by nerves exhaust immune cells in humans […]
July 30, 2023
NOMIS researcher Janelle Ayres and colleagues at the Salk Institute have discovered that CD8+ T cells initiate the process of muscle wasting during infection, and this muscle wasting helped mice […]
July 1, 2023
NOMIS researcher Susan Kaech and colleagues at the Salk Institute have unraveled the “BAFfling” puzzle of how infection- and cancer-fighting immune cells develop in mice. Their findings were published in […]
June 25, 2023
NOMIS researcher Janelle Ayres and fellow Salk Institute colleagues have found that pairing specific diets with disease-causing bacteria can create lasting immunity in mice without the costs of developing sickness, […]
April 24, 2023
NOMIS researcher Susan Kaech has been elected to the American Academy of Arts and Sciences. LA JOLLA—Salk Institute Professor Susan Kaech, director of the NOMIS Center for Immunobiology and Microbial Pathogenesis, […]
December 13, 2022
NOMIS Awardee Ronald Evans, NOMIS researcher Ye Zheng and colleagues have published in Proceedings of the National Academy of Sciences their findings showing that a compound they developed, FexD, can […]
June 23, 2022
Study highlights how current treatments for alopecia work on a cellular level NOMIS researcher Ye Zheng and fellow Salk scientists have uncovered an unexpected molecular target of a common treatment […]
March 30, 2022
NOMIS Awardee Ronald Evans, NOMIS researcher Ye Zheng and their colleagues have discovered why immune treatments for allergies and asthma might not be as effective in obese mice and humans. […]
October 18, 2021
The NOMIS Center Postdoctoral Fellowship Program at the Salk Institute has been featured in an advertorial in Science. The article details the research projects of NOMIS Fellows Dan Chen, Lidia Jiménez, Andre Mu and […]
August 23, 2021
NOMIS researcher Janelle Ayres has been named the Salk Institute Legacy Chair. Ayres leads the Harnessing Physiological Health to Treat Disease project and is a professor in the NOMIS Center […]
June 11, 2021
NOMIS researcher Susan Kaech and colleagues have identified how tumors cause immune cells to lose their ability to fight cancer, opening new avenues for therapies. LA JOLLA—In order for cancer to […]
April 16, 2021
NOMIS researcher Greg Lemke and colleagues at the Salk Institute have found that the brain’s immune cells form some plaques as a defense in Alzheimer’s disease, suggesting a new therapeutic […]
December 21, 2020
In an article published on Dec. 7, 2020, Newsweek explores Alzheimer’s disease, highlighting the research of NOMIS scientist Eric Reiman and Salk Institute of Biological Studies president Rusty Gage. BY […]
November 30, 2020
Susan Kaech, NOMIS Foundation Chair and director of the NOMIS Center for Immunobiology and Microbial Pathogenesis at the Salk Institute, has been named a 2020 Fellow of the American Association […]
September 20, 2020
NOMIS scientist and board member Martin Hetzer and his colleagues at the Salk Institute for Biological Studies have discovered the ways cells from the human circulatory system change with age […]
August 24, 2020
NOMIS Awardee Ronald M. Evans and fellow Salk researchers have developed transplantable human cells that make insulin, controlling blood sugar without immunosuppressants in mouse models. LA JOLLA—Salk Institute scientists have […]
June 29, 2020
Salk scientists tackle COVID-19 pandemic with innovative research projects on immunity, vaccine development, viral imaging and more LA JOLLA—As the COVID-19 pandemic continues across the globe, the Salk Institute joins […]
June 12, 2020
NOMIS scientist Susan Kaech, who is director of the Salk Institute’s NOMIS Center for Immunobiology and Microbial Pathogenesis, has published her findings that the cells responsible for long-term immunity in […]
June 5, 2020
NOMIS researcher Martin Hetzer, who is also a NOMIS board member, has published a study detailing how cells remember their identity. How Cells Solve Their Identity Crisis Salk scientists uncover […]
May 11, 2020
NOMIS researcher Janelle Ayres, a molecular and systems physiologist at the NOMIS Center for Immunobiology and Microbial Pathogenesis at the Salk Institute for Biological Studies, has published an editorial on […]
May 8, 2020
The Salk Institute for Biological Studies, a long-time NOMIS Foundation partner, has published a video highlighting the COVID-19 research taking place at Salk. Salk has been a NOMIS partner since […]
August 27, 2019
Salk scientists find how to block inflammatory molecules in mouse model of multiple sclerosis LA JOLLA—Your immune system comes ready for battle against bacteria, viruses, fungi and even cancer. But […]
September 19, 2018
NOMIS scientist Martin Hetzer and other Salk Institute researchers have devised a way to manipulate numbers of individual nuclear pores — a breakthrough that may one day stop cancerous cells […]
August 10, 2018
Salk Institute researcher Janelle Ayres and her colleagues report that giving mice dietary iron supplements enabled them to survive a normally lethal bacterial infection and resulted in later generations of […]
June 28, 2018
Janelle Ayres of the Salk Institute for Biological Studies has won the Blavatnik National Award for Young Scientists, one of the world’s largest unrestricted prizes for early career scientists. Ayres is […]
June 1, 2018
Janelle Ayres of the Salk Institute for Biological Studies has been named by the Blavatnik National Awards for Young Scientists as one of 31 US national finalists for the world’s largest unrestricted prizes […]
January 8, 2018
Salk researchers have identified the molecular target of J147. The experimental drug is something of a modern elixir of life; it’s been shown to treat Alzheimer’s disease and reverse aging in […]
January 7, 2018
Scientists at the Salk Institute have published the results of a study in the journal Aging Cell, showing the novel molecular link between aging and dementia through the identification of the […]
September 29, 2017
TIME’s powerful series, “TIME Firsts: Women Who Are Changing the World,” profiles Salk Institute President Elizabeth Blackburn, the first woman president of the institute. Blackburn won the 2009 Nobel Prize in […]
September 5, 2017
Supported by the NOMIS Foundation and the Glenn Center for Aging Research, researchers at the Salk Institute probing the premature aging disorder Hutchinson-Gilford progeria have uncovered an errant protein process in […]
July 19, 2017
Susan Kaech, currently professor of Immunobiology at Yale University, will join Salk as NOMIS Foundation Chair and director of the NOMIS Center for Immunobiology and Microbial Pathogenesis beginning in 2018. Kaech […]
November 29, 2016
Researchers at the Salk Institute in La Jolla, California, have discovered how immune receptors use a protein to amplify “invader” signals and attack a biological intruder. The T cell receptor […]
November 29, 2016
Salk Institute scientists in La Jolla, California have published in the Nov. 2 issue of Genes & Development a study demonstrating that the nuclear membrane acts not only as a […]
November 29, 2016
In a conversation with Inside Salk, Ye Zhen, associate professor at the NOMIS Foundation Laboratories for Immunbiology and Microbial Pathogenesis, shares his hopes and his hesitations about tapping our immune […]
November 26, 2016
Dr. Janelle Ayres, researcher at the NOMIS Center for Immunbiology and Microbial Pathogenesis, addresses the disconnect between our methods for treating infectious disease and our understanding of the mechanisms that […]